The outcomes assessed were liver histology including steatosis, inflammation, and fibrosis; liver markers, including alanine aminotransferase (AST) and aspartate aminotransferase (ALT); and lipid profile, including high-density lipoproteins (HDLs), low-density lipoproteins (LDLs), and triglycerides. The gene discussed is GPT; the disease is steatosis.